The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis
Abstract
OBJECTIVES: Procalcitonin (ProCT), the precursor to the calcitonin hormone, is abnormally increased in experimental and clinical systemic inflammation, including sepsis. Initially, we investigated the effects of supraphysiologic amounts of ProCT administered to animals with septic peritonitis. Subsequently, we evaluated the efficacy of prophylactic and therapeutic immune blockade of ProCT in this lethal model of sepsis. DESIGN: Prospective, experimental, controlled study. SETTING: Animal research laboratory approved by the American Association for the Accreditation of Laboratory Animal Care at a Veterans Affairs Medical Center. SUBJECTS: Young male Golden Syrian hamsters, weighing 90 to 120 g. INTERVENTIONS: In the first study, serum ProCT concentrations were measured in animals at 0, 3, 6, 12, and 24 hrs after induction of sepsis by intraperitoneal implantation of pellets containing Escherichia coli (5 x 10(8) colony-forming units/pellet). In the second study, with mortality as the end point, 30 microg/kg of isolated, purified human ProCT in 10% hamster serum (experimental) or an equal volume of 10% hamster serum (control) were administered intravenously at the time of the E. coli peritoneal implantation. In the third study, experimental animals received intraperitoneal injections of a multiregion-specific goat antiserum reactive to hamster ProCT 1 hr before and 24 hrs after E. coli implantation, while control animals received nonimmune goat serum at the same time points. In the final study, the same antiserum was administered in five divided doses during the 24 hrs after the insertion of E. coli. MEASUREMENTS AND MAIN RESULTS: In the initial study, ProCT concentrations were increased shortly after induction of sepsis and peaked at 12 hrs. Administration of exogenous ProCT to septic animals significantly increased mortality compared with control animals (93% vs. 43%, p=.02). Prophylactic blockade of ProCT almost completely protected the animals from the lethal effects of sepsis: the 102-hr mortality rate in the experimental group was 6% compared with 62% in the control group (p < .003). In the therapeutic trial, the 102-hr mortality rate was 54% in experimental animals compared with 82% in control animals (p < .045). CONCLUSIONS: These results demonstrate that increased ProCT exacerbates mortality in experimental sepsis, whereas neutralization of ProCT increases survival. Thus, ProCT, in addition to being an important marker of severity of systemic inflammation and mortality, is an integral part of the inflammatory process and directly affects the outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
High serum procalcitonin concentrations in patients with sepsis and infection
Assicot, M., Bohuon, C., Gendrel, D., Raymond, J., Carsin, H., & Guilbaud, J. (1993) · The Lancet · doi:10.1016/0140-6736(93)90277-n · Cited by 2,197
Procalcitonin increase after endotoxin injection in normal subjects
Dandona, P. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.6.1605 · Cited by 965
Anti-inflammatory therapies to treat sepsis and septic shock: A reassessment
Zeni, F., Freeman, B., & Natanson, C. (1997) · Critical Care Medicine · doi:10.1097/00003246-199707000-00001 · Cited by 648
Friedland, J. S., Porter, J. C., Daryanani, S., Bland, J. M., Screaton, N. J., Vesely, M. J. J., Griffin, G. E., Bennett, E., & Remick, D. G. (1996) · Critical Care Medicine · doi:10.1097/00003246-199611000-00003 · Cited by 129
Strategies for blocking the systemic effects of cytokines in the sepsis syndrome
Christman, J. W., Holden, E. P., & Blackwell, T. S. (1995) · Critical Care Medicine · doi:10.1097/00003246-199505000-00027 · Cited by 103
Linnoila, R. I., Kl, B., Silva, O. L., Snider, R., & Cf, M. (1984) · PubMed · Cited by 49
Self-citationLind, L., Bucht, E., & Ljunghall, S. (1995) · Intensive Care Medicine · doi:10.1007/bf02425156 · Cited by 30
Opdahl, H. (1997) · Critical Care Medicine · doi:10.1097/00003246-199708000-00035 · Cited by 28
Cholinergic‐nicotinic control of growth and secretion of cultured pulmonary neuroendocrine cells
Nylén, E., Becker, K. L., Snider, R. H., Tabassian, A. R., CASSIDY, M. M., & Linnoila, R. I. (1993) · The Anatomical Record · doi:10.1002/ar.1092360117 · Cited by 27
Self-citation
Cited by
Procalcitonin Guidance of Antibiotic Therapy in Community-acquired Pneumonia: A Randomized Trial
Christ-Crain, M., Stolz, D., Bingisser, R., Müller, C., Miedinger, D., Huber, P. R., Zimmerli, W., Harbarth, S., Tamm, M., & Müller, B. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200512-1922oc · Cited by 884
Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit
Müller, B., Becker, K. L., Schächinger, H., Rickenbacher, P. R., Huber, P. R., Zimmerli, W., & Ritz, R. (2000) · Critical Care Medicine · doi:10.1097/00003246-200004000-00011 · Cited by 628
Self-citationBecker, K. L., Snider, R., & Nylen, E. S. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e318165babb · Cited by 598
Self-citationBecker, K. L., Nylén, E. S., White, J. C., Müller, B., & Snider, R. H. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021444 · Cited by 578
Self-citationUbiquitous Expression of the Calcitonin-I Gene in Multiple Tissues in Response to Sepsis1
Müller, B., White, J. C., Nylén, E. S., Snider, R. H., Becker, K. L., & Habener, J. F. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7089 · Cited by 440
Self-citation
Metadata
- Authors
- Nylen, E. S., Whang, K. T., Snider, R. H., Steinwald, P. M., White, J. C., & Becker, K. L.
- Venue
- Critical Care Medicine
- Published
- 1998-06
- Volume
- 26
- Issue
- 6
- Pages
- 1001-1006
- ISSN
- 0090-3493 (ISSN-L)
- OpenAlex
- W2004556024
- Cited by
- 327
- References
- 14
- FWCI
- 19.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. https://app.cochat.ai/papers/10.1097/00003246-199806000-00015
- The paper
- Nylen, E. S., Whang, K. T., Snider, R. H., Steinwald, P. M., White, J. C., & Becker, K. L. (1998). Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. Critical Care Medicine. https://doi.org/10.1097/00003246-199806000-00015
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.